Compare Johnson Controls International PLC (JCI) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson Controls International PLC vs Twist Bioscience Corp — how do they compare? Johnson Controls International PLC trades at $157.44 (market cap $93.28B), while Twist Bioscience Corp trades at $159.78 (market cap $10.08B). The key difference: Johnson Controls International PLC is far larger — about 9.3× Twist Bioscience Corp's market cap, and Johnson Controls International PLC pays a 1.04% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Johnson Controls International PLC for 65 Days and Twist Bioscience Corp for 27 Days on average.
| JCI | TWST | |
|---|---|---|
Market Cap | $93.28B | $10.08B |
Volume | 2,786,476 | 4,229,037 |
Sector | Basic Materials | Health |
52-Week High | $158.76 | $205.00 |
52-Week Low | $105.55 | $25.45 |
Typical Hold Time | 65 Days | 27 Days |
Enterprise Value | $102.12B | $10.01B |
Dividend Yield | 1.04% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson Controls International (JCI) trades at $154.00, down 1.24% on the day, but maintains a bullish technical outlook with strong analyst support. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 results showing 10% organic sales growth and a raised full-year outlook. Valuation ratios are elevated, but profitability metrics like a 14.32% net income margin and 24.42% ROE reflect solid fundamental strength.
The outlook for JCI is positive, driven by robust demand for its building systems and data center thermal management solutions. Key opportunities include continued execution on record backlog and AI-driven industrial stock tailwinds. Risks involve high debt levels and sensitivity to economic cycles. With a consensus price target of $172.50 implying ~12% upside, Wall Street sentiment remains bullish.
TWST trades at $152.05, down 2.31% today, with a mixed technical picture showing bullish overall signals but bearish moving averages. The company reported Q2 2026 EPS of -$0.56, missing expectations, continuing a trend of losses despite revenue growth to $376.57M in 2025. Recent news highlights a partnership with Lilly TuneLab for AI-driven drug discovery, driving investor optimism.
Outlook remains speculative with high valuation multiples (P/S 21.5, P/B 22.62) and persistent losses, but analyst consensus is bullish (73% buy ratings) with a $145.20 price target. Key risks include cash burn, competitive pressures, and reliance on AI-driven growth catalysts for profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson Controls International PLC
Johnson Controls manufactures, installs, and services HVAC systems, building management systems and controls, industrial refrigeration systems, and fire and security solutions. Commercial HVAC accounts for about 40% of sales, fire and security also represents 40% of sales, and residential HVAC, industrial refrigeration, and other solutions account for the remaining 20% of revenue. In fiscal 2021, Johnson Controls generated over $23.5 billion in revenue.
Read more on JCI →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
